ALEZURIS

Serial Number 97220752
606

Registration Progress

Application Filed
Jan 14, 2022
Under Examination
Sep 27, 2022
Approved for Publication
Aug 2, 2022
Published for Opposition
Aug 2, 2022
Registered

Trademark Image

ALEZURIS

Basic Information

Serial Number
97220752
Filing Date
January 14, 2022
Published for Opposition
August 2, 2022
Abandonment Date
May 1, 2023
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
May 1, 2023
Classes
005

Rights Holder

Tricida, Inc.

03
Address
7000 Shoreline Court, Suite 201
South San Francisco, CA 94080

Ownership History

Tricida, Inc.

Original Applicant
03
South San Francisco, CA

Tricida, Inc.

Owner at Publication
03
South San Francisco, CA

Legal Representation

Attorney
Katherine A. Keating

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

10 events
Date Code Type Description Documents
May 1, 2023 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
May 1, 2023 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Sep 27, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 2, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 2, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 13, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 28, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 28, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 21, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 18, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of metabolic acidosis associated with chronic kidney disease; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for increasing bicarbonate levels; non-absorbed pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of metabolic acidosis and renal disorders; polymeric pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of metabolic acidosis and renal disorders; non-absorbed polymer for treatment of metabolic acidosis associated with kidney disease

Classification

International Classes
005